Forte Biosciences Inc (FBRX)
0.77
-0.01
(-1.28%)
USD |
NASDAQ |
Apr 19, 16:00
0.77
0.00 (0.00%)
After-Hours: 18:12
Forte Biosciences Market Cap: 28.02M for April 19, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 18, 2024 | 28.39M |
| April 17, 2024 | 26.93M |
| April 16, 2024 | 26.70M |
| April 15, 2024 | 25.84M |
| April 12, 2024 | 26.32M |
| April 11, 2024 | 26.20M |
| April 10, 2024 | 26.57M |
| April 09, 2024 | 26.26M |
| April 08, 2024 | 25.51M |
| April 05, 2024 | 25.44M |
| April 04, 2024 | 26.57M |
| April 03, 2024 | 25.29M |
| April 02, 2024 | 26.12M |
| April 01, 2024 | 25.75M |
| March 28, 2024 | 25.34M |
| March 27, 2024 | 25.29M |
| March 26, 2024 | 25.83M |
| March 25, 2024 | 25.84M |
| March 22, 2024 | 25.49M |
| March 21, 2024 | 25.11M |
| March 20, 2024 | 25.45M |
| March 19, 2024 | 24.02M |
| March 18, 2024 | 23.41M |
| March 15, 2024 | 22.56M |
| March 14, 2024 | 23.62M |
| Date | Value |
|---|---|
| March 13, 2024 | 23.58M |
| March 12, 2024 | 24.46M |
| March 11, 2024 | 25.80M |
| March 08, 2024 | 27.51M |
| March 07, 2024 | 27.96M |
| March 06, 2024 | 26.89M |
| March 05, 2024 | 25.91M |
| March 04, 2024 | 25.08M |
| March 01, 2024 | 26.29M |
| February 29, 2024 | 24.81M |
| February 28, 2024 | 26.16M |
| February 27, 2024 | 24.90M |
| February 26, 2024 | 25.11M |
| February 23, 2024 | 25.07M |
| February 22, 2024 | 24.02M |
| February 21, 2024 | 24.94M |
| February 20, 2024 | 25.43M |
| February 16, 2024 | 25.09M |
| February 15, 2024 | 25.27M |
| February 14, 2024 | 25.07M |
| February 13, 2024 | 24.00M |
| February 12, 2024 | 24.85M |
| February 09, 2024 | 22.89M |
| February 08, 2024 | 22.71M |
| February 07, 2024 | 21.25M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
13.81M
Minimum
Nov 15 2023
574.25M
Maximum
Jun 07 2021
147.30M
Average
26.44M
Median
Aug 15 2022
Market Cap Benchmarks
| CEL-SCI Corp | 83.94M |
| AIM ImmunoTech Inc | 23.50M |
| IGC Pharma Inc | 32.06M |
| NovaBay Pharmaceuticals Inc | 2.441M |
| Protalix BioTherapeutics Inc | 84.38M |
Market Cap Related Metrics
| Price to Book Value | 0.7936 |
| Price | 0.77 |
| Earnings Yield | -135.1% |